Nicholas Vogelzang
8PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 19, 2022
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.Sarmad Sadeghi, David Quinn, Tanya Dorff
|Apr 21, 2022
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain
|Mar 05, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.Joaquim Bellmunt, Ronald de Wit, Yves Fradet
|Jan 20, 2022
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.Kyrillus S Shohdy, Dario M Villamar, Yen Cao
|Oct 02, 2021
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study.Andrea Loehr, Akash Patnaik, David Campbell
|Jul 06, 2021
Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer.Amber S Kleckner, Megan Wells, Lee A Kehoe
Pageof 2
Frequent Collaborators
4 joint publications
David Quinn
2 joint publications
Alan H Bryce
2 joint publications
Andrew D Simmons
2 joint publications
Simon P Watkins
2 joint publications
Tony Golsorkhi
2 joint publications
Manish Kohli
2 joint publications
Neeraj Agarwal
2 joint publications
Primo N Lara
2 joint publications
Cora N Sternberg
1 joint publications
Alexander Cunha
